CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
CERO THERAPEUTICS HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $253.05K
- P/E (TTM)
- –
- Dividend yield
- 172833.33%
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
$10.37
Consecutive increases
0 years
Not raised last year
Dividend yield
172833.33%
Latest annual dividend ÷ share price
Payout ratio, FY2025
-0.6%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | $10.37 | – | $127.14K | -0.6% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.